ARTICLE | Clinical News
SMT19969: Phase II start
March 24, 2014 7:00 AM UTC
This half, Summit will begin the double-blind, North American Phase II CoDIFy trial to compare 200 mg oral SMT19969 twice daily vs. 125 mg oral vancomycin given 4 times a day for 10 days in about 100 ...